Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • covid treatment

Tag: covid treatment

  • BiotechToday
  • World

How statins lower the death rate in COVID-19 patients

bioxone July 19, 2021July 19, 2021 1

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Despite the improving research methodologies and treatments, COVID-19 continues to spread, causing deaths and morbidity across the world. It has been found that statins can potentially decrease the severity of COVID-19. However, this field has been less researched due to limited size and region-centred studies.  Statins […]

Read More
  • BiotechToday
  • World

A drug to reduce Covid infection by 99%

BioTech Today June 29, 2021June 28, 2021 5

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University All over the world research is currently focused on the development of a drug that might help cure COVID19. At the moment we do not have any treatment for COVID19. Vaccines are the only way the chain of transmission can be broken. Throughout the pandemic, various drugs […]

Read More
  • BiotechToday
  • India

PLASMA THERAPY – DEAD END FOR COVID-19?

bioxone October 29, 2020October 29, 2020 2

Aishila Kar, Amity University Kolkata In New Delhi, since ILBS Hospital, initiates its plasma bank from July, requests have poured in continuously. Jai Prakash said that when someone close to you is about to die, you will take whatever form of hope you can find, age of 44, who obtained plasma last month for his […]

Read More
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Read More
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Read More
  • BiotechToday
  • India
  • World

Elevation of serum IgA and antiphospholipid-IgA antibodies production in Severe COVID-19

bioxone October 2, 2020October 2, 2020

Anwita Sarkar, Team BioXone Based on what we know so far about the complications of COVID-19, it frequently involves complications that bear similarities to autoimmune disorders. Up to now, there are little reports on possible IgA mediated autoimmune responses. A study was conducted to determine the association of COVID-19 with vigorous total IgA responses. It […]

Read More
  • BiotechToday
  • India

Big breakthrough! ICMR and BIOLOGICAL E LTD develop a potential treatment for Covid-19

bioxone October 2, 2020October 2, 2020 1

-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]

Read More
  • BiotechToday
  • World

Catalase: Antioxidant Treatment for COVID-19

bioxone October 2, 2020October 1, 2020 1

-Thota Kanishka Rao, Amity University Kolkata Researchers have discovered that a drug, Catalase, might be the solution to the ongoing coronavirus pandemic. Catalase is a naturally occurring enzyme having the potential as a therapeutic drug treat COVID-19 symptom and suppress the replication of the virus inside the body. Catalase is produced naturally and employed by […]

Read More
  • BiotechToday
  • World

Efficacy of the two PCR kits for SARS-CoV-2 nucleic acid Detection

bioxone October 1, 2020September 30, 2020 3

-Srilagna Sarkar, Amity University Kolkata To compare the diagnostic efficacy of the two different reverse transcription-polymerase chain reaction (RT-PCR) test kits. Throat swab samples from 18 hospitalized patients who were clinically tested for COVID-19 and from 100 hospitalized patients who were COVID negative were taken.SARS-CoV-2 nucleic acid was detected in throat swab samples of the […]

Read More
  • BiotechToday
  • World

COVID-19: Extracorporeal carbon dioxide removal as rescue therapy in severe Covid-19 pneumonitis

bioxone September 26, 2020September 26, 2020 9

  Srilagna Sarkar, Amity University Kolkata Coronavirus disease 2019, was first identified in Wuhan where 27 patients cases reported of pneumonia of some unknown aetiology were linked with an open seafood market. Despite several measures, the virus spread rapidly and by 11 March 2020 WHO declared it as a global pandemic. In the majority of patients […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy